Molecular markers for colorectal cancer screening

Area of Science:

• Oncology
• Molecular Biology
• Gastroenterology

Background:

• Colorectal cancer (CRC) remains a significant global health concern.
• Programmatic screening has led to decreased CRC incidence and mortality in some regions.
• Current screening methods include fecal occult blood testing and endoscopy.

Purpose of the Study:

• To explore innovative molecular markers for accurate, non-invasive colorectal cancer screening.
• To evaluate the potential of stool DNA as a promising biomarker for CRC detection.
• To discuss the development and clinical utility of advanced stool DNA testing.

Main Methods:

• Evaluation of various molecular markers (DNA, RNA, proteins) in stool samples.
• Focus on stool DNA due to tumor cell exfoliation and DNA stability.
• Development of multi-target stool DNA tests combining mutant/methylated DNA markers and FIT.

Main Results:

• A multi-target stool DNA test demonstrated favorable performance in a large validation study.
• This novel test has received FDA approval for screening asymptomatic, average-risk individuals.
• The test integrates multiple molecular markers for enhanced colorectal cancer detection.

Conclusions:

• Stool DNA testing represents a significant advancement in non-invasive colorectal cancer screening.
• Further research is needed to optimize screening intervals and compliance for these new assays.
• Clinical integration requires studies on managing false positives and use in high-risk populations.